Sujith Ayyappan
Sujith Ayyappan publishes mostly in Neurology, Psychiatry and Mental health and Endocrinology, Diabetes and Metabolism, on topics such as Myasthenia Gravis and Thymoma, Autoimmune Neurological Disorders and Treatments and Cerebrospinal fluid and hydrocephalus.
- World rank
- #4,033,823 of 7,710,434 ranked researchers
- Rank in Australia
- #101,113 of 140,210
- Works
- 15
- Citations
- 154
- Citations per work
- 10.3
What does Sujith Ayyappan research?
Sujith Ayyappan's work is mostly in Medicine (56%), Neuroscience (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences855.9%
- Medicine855.9%
- Everything else637.1%
- Life Sciences17.0%
- Neuroscience17.0%
- 1Neurology23% of their works
- 2Psychiatry and Mental health9% of their works
- 3Endocrinology, Diabetes and Metabolism9% of their works
- 4Oncology7% of their works
- 5Cellular and Molecular Neuroscience7% of their works
- 6Pediatrics, Perinatology and Child Health7% of their works
Research topics
- Myasthenia Gravis and Thymoma
- Autoimmune Neurological Disorders and Treatments
- Cerebrospinal fluid and hydrocephalus
- Pituitary Gland Disorders and Treatments
- Peripheral Neuropathies and Disorders
- Cancer Treatment and Pharmacology
- Parasitic infections in humans and animals
- Prion Diseases and Protein Misfolding
Which keywords describe Sujith Ayyappan's research?
The keywords of their largest research topics: Neurological Disorders, Autoantibodies, Immunotherapy, Epidemiology, Prognosis, Diagnosis, Treatment and Anti-NMDA Receptor Encephalitis.
- Molecular Basis
- Pituitary Adenomas
- Guillain-Barré Syndrome
- Echinococcosis
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Cerebrospinal Fluid
- Paraneoplastic Syndromes
- Anti-NMDA Receptor Encephalitis
- Diagnosis
- Epidemiology
- Autoantibodies
- Neurological Disorders
- Immunotherapy
- Prognosis
- Treatment
- Myasthenia Gravis
- Thymic Tumors
- Chemotherapy-Induced Peripheral Neuropathy
- Cushing's Syndrome
- Glymphatic System
- Neurocysticercosis
- Taxanes
- Prion Diseases
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Neurological Disorders73 topics
- Autoantibodies62 topics
- Immunotherapy62 topics
- Epidemiology52 topics
- Prognosis52 topics
- Diagnosis42 topics
- Treatment42 topics
- Anti-NMDA Receptor Encephalitis31 topic
- Myasthenia Gravis31 topic
- Paraneoplastic Syndromes31 topic
- Thymic Tumors31 topic
- Cerebrospinal Fluid21 topic
- Chemotherapy-Induced Peripheral Neuropathy21 topic
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy21 topic
- Cushing's Syndrome21 topic
- Echinococcosis21 topic
- Glymphatic System21 topic
- Guillain-Barré Syndrome21 topic
- Neurocysticercosis21 topic
- Pituitary Adenomas21 topic
- Taxanes21 topic
- Molecular Basis11 topic
- Prion Diseases11 topic
Where does Sujith Ayyappan work?
Sujith Ayyappan's main affiliation in the publication record is Barwon Health, Australia.
How many publications and citations does Sujith Ayyappan have?
OpenAlex counts 15 works and 154 citations for Sujith Ayyappan, an h-index of 5, ranking #4,033,823 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Sujith Ayyappan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.